Mary Dejevsky: Genetic testing has little value if there's no chance of a cure

If you submit to screening at, say, the age of 40, and learn that you have a predisposition to Alzheimer's, what are you supposed to do about it?

Share
Related Topics

Sometimes it is hard not to feel that the media and the medics between them have things the wrong way round. Earlier this week, a report from the Human Genetics Commission recommended that genetic testing for a range of conditions be made available to couples contemplating having children. The findings have more committees to pass through before they are acted upon, but the Commission said that there were "no specific social, ethical or legal principles" against pre-conception screening. At this point, the whole subject sank like a stone.

Go back a week, though, and another report made far bigger, far noisier waves. Scientists from the universities of Cardiff and Pennsylvania announced the identification of five gene variants that raise the risk of Alzheimer's disease. Much was made of the numbers likely to suffer from Alzheimer's (an estimated 1 million by 2021) and the cost of care (currently £23bn a year). It is not the scientists' fault, but the tenor of the reporting suggested that prevention or cure might be just around the corner.

There are some obvious reasons why these two items of news from the medical genetics front were received so differently. One is that Alzheimer's, second only to a cancer diagnosis, is the fate very many people fear, for ageing relatives and for themselves. Another is that the Alzheimer's research appeared to offer unadulterated good news: quantifiable progress towards a much-desired end – five whole new gene variants found at once. The news about pre-conception screening, on the other hand, held out no hope of cures and could be interpreted as potentially blighting a couple's hopes.

Of these two developments, however, I would argue that the possibility for couples to be screened for conditions they might pass on is by far the more significant and beneficial here and now. Discovering genetic markers for Alzheimer's is still – if you read the small print of last week's reports – at a very early stage; thus far, there is no single one that determines whether someone will develop Alzheimer's, and there may never be. It may always be a combination of different genetic variants and environmental factors.

The crucial distinction in my mind, however, is that pre-conception screening allows individuals to make an informed choice. They are tested for the propensity to pass on a condition that has already been identified – which, of course, is by no means all. They can then consider what to do about it. That might entail a decision not to have children. It might mean exploring the options for test-tube screening of embryos. It might prompt a subsequent decision to end a pregnancy, or even a relationship – but surely better at that point than for one or other parent to conclude later that they cannot or do not want to cope. At very least it would mean that if the couple decide to have children, they are forewarned and so forearmed.

With Alzheimer's, it is not just that knowledge about the genetic components is still at a very preliminary stage, but that the possibilities even for slowing, let alone preventing the onset of the condition, are extremely limited. If you submit to screening at, say, the age of 40, and learn that you have a predisposition, to some unknown degree, to Alzheimer's, what are you supposed to do about it? It is difficult not to believe that the awareness alone would not in some way overshadow your whole life, as you kept watch for seemingly tell-tale symptoms. If and when an effective treatment is developed, through drugs or gene therapy, the calculation will change. But even at the speed with which the science of genetics is advancing, prevention or cure looks many years away.

At least a system of universal access to healthcare, such as most European countries maintain in one form or other, obviates the other great risk that arises from genetic testing. It was President Clinton who decreed that commercial health insurance companies in the United States should not be able to weight policies according to the results of genetic testing. As genetics advances, however, the line will be ever harder to hold, as insurers press for the knowledge that holds the key to certain profits. This is why the US health insurance model, even as liberalised by Barack Obama, is likely one day to become unsustainable, as it seeks to lock out those predisposed to develop one expensive debilitating condition or another.

Regardless of the uniquely ruthless US health insurance system, however, it is worth asking whether there is not something unethical about offering people genetic tests for conditions that are not – or not yet – treatable. This is not a problem with pre-conception testing, as the question posed is quite different, and, whatever the results, there is a remedy. But what about genetic testing for Alzheimer's?

As someone whose husband has what may well be an inherited form of Parkinson's disease, where genetic research seems to be at a similar stage to that of Alzheimer's, I am not sure what practical purpose testing would serve. When we married, the burden of scientific opinion was that Parkinson's was not inherited. His own family history suggested otherwise. Now, much of the research being conducted around the world is geared towards identifying genetic mutations, with one – known as LRRK2 – strongly associated with a strain of Parkinson's that manifests itself long before old age. It is possible to test for this.

At the World Parkinson's Congress, held in Glasgow last year, an American radio journalist recently diagnosed with the condition, who had a father and a brother who were also sufferers, described his dilemma on being offered such a test. After consulting close family, he declined. He never actually said why, and maybe his grown-up children feared pressure to be tested, too, and the possible effects of such knowledge on their quality of life and insurability. But it is possible to imagine, too, that, with no treatment available, he felt the scales of advantage weighted against him. Altruism might militate in favour of taking a test, for the sake of medical research; his own long-considered preference was not to know. And who can blame him? Perhaps it is part of the human condition not to bow to determinism until you have to.

m.dejevsky@independent.co.uk

React Now

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
iJobs Job Widget
iJobs General

Recruitment Genius: Finance Director

£65000 - £80000 per annum: Recruitment Genius: Finance Director required to jo...

Recruitment Genius: Medico-Legal Assistant

£15000 - £25000 per annum: Recruitment Genius: This is a unique opportunity fo...

Ashdown Group: (PHP / Python) - Global Media firm

£50000 per annum + 26 days holiday,pension: Ashdown Group: A highly successful...

The Jenrick Group: Quality Inspector

£27000 per annum + pension + holidays: The Jenrick Group: A Quality Technician...

Day In a Page

Read Next
David Cameron faces the press as he arrives in Brussels for the EU leaders summit on Thursday reuters  

On the Tusk of a dilemma: Cameron's latest EU renegotiation foe

Andrew Grice
John Profumo and his wife Valerie Robson in 1959  

Stephen Ward’s trial was disgraceful. There can be no justification for it

Geoffrey Robertson QC
Amir Khan: 'The Taliban can threaten me but I must speak out... innocent kids, killed over nothing. It’s sick in the mind'

Amir Khan attacks the Taliban

'They can threaten me but I must speak out... innocent kids, killed over nothing. It’s sick in the mind'
Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture